Status:
COMPLETED
Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Canadian Cancer Society (CCS)
Conditions:
Prostate Cancer
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health car...
Detailed Description
Guidelines for prostate screening in Canada are based on low-moderate quality evidence of effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs) are tools that as...
Eligibility Criteria
Inclusion
- English speaking men, \> 50 years old
Exclusion
- History of prostate cancer or PSA test in the last 12 months
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
308 Patients enrolled
Trial Details
Trial ID
NCT03477591
Start Date
October 1 2018
End Date
July 1 2021
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada, L8P0A1